UNLABELLED: In order to establish its usefulness for the diagnosis and follow-up of thyroid autoimmune diseases, thyroid ultrasonography together with free T4 (FT4), free T3 (FT3), TSH, antibodies (Tg Ab) and thyroperoxidase antibodies (TPO Ab) were performed and re-evaluated during a 3-yr follow-up in 482 apparently healthy subjects, living in a borderline iodine-sufficient urban area. Thyroid dysfunction was found in 7 out of 12 (58.3%) subjects with circulating thyroid autoantibodies, who also had thyroid hypoechogenicity (2 had overt and 3 subclinical hypothyroidism at booking; 2 developed subclinical hypothyroidism during the follow-up), and in none of the 12 subjects with normal thyroid echostructure (chi2=7.26, p=0.007). Thyroid dysfunction was found in 4 out of 29 (13.7%) subjects with negative Tg and/or TPO Ab who also had thyroid hypoechogenicity (1 had Graves' disease at booking, 1 developed Graves' disease and 2 subclinical hypothyroidism during the follow-up), and in none of the 429 with normal thyroid echostructure (chi2=82.03, p<0.0001). Although positive TPO and/or Tg Ab were more frequent (24/482, 5%) in subjects with thyroid dysfunction (7/11) than in those who remained euthyroid during the study (17/471, chi2=69.66, p<0.0001), thyroid hypoechogenicity had a higher sensitivity than the positivity of thyroid autoantibody tests (100 vs 63.3%) for diagnosing or predicting thyroid dysfunction. IN CONCLUSION: 1) thyroid ultrasonography is a useful tool to detect thyroid autoimmune disease in apparently healthy subjects; 2) present and future thyroid dysfunction is more readily predicted by a hypoechogenic pattern at thyroid ultrasound than by the occurrence of serum thyroid autoantibodies.
UNLABELLED: In order to establish its usefulness for the diagnosis and follow-up of thyroid autoimmune diseases, thyroid ultrasonography together with free T4 (FT4), free T3 (FT3), TSH, antibodies (Tg Ab) and thyroperoxidase antibodies (TPO Ab) were performed and re-evaluated during a 3-yr follow-up in 482 apparently healthy subjects, living in a borderline iodine-sufficient urban area. Thyroid dysfunction was found in 7 out of 12 (58.3%) subjects with circulating thyroid autoantibodies, who also had thyroid hypoechogenicity (2 had overt and 3 subclinical hypothyroidism at booking; 2 developed subclinical hypothyroidism during the follow-up), and in none of the 12 subjects with normal thyroid echostructure (chi2=7.26, p=0.007). Thyroid dysfunction was found in 4 out of 29 (13.7%) subjects with negative Tg and/or TPO Ab who also had thyroid hypoechogenicity (1 had Graves' disease at booking, 1 developed Graves' disease and 2 subclinical hypothyroidism during the follow-up), and in none of the 429 with normal thyroid echostructure (chi2=82.03, p<0.0001). Although positive TPO and/or Tg Ab were more frequent (24/482, 5%) in subjects with thyroid dysfunction (7/11) than in those who remained euthyroid during the study (17/471, chi2=69.66, p<0.0001), thyroid hypoechogenicity had a higher sensitivity than the positivity of thyroid autoantibody tests (100 vs 63.3%) for diagnosing or predicting thyroid dysfunction. IN CONCLUSION: 1) thyroid ultrasonography is a useful tool to detect thyroid autoimmune disease in apparently healthy subjects; 2) present and future thyroid dysfunction is more readily predicted by a hypoechogenic pattern at thyroid ultrasound than by the occurrence of serum thyroid autoantibodies.
Authors: P Vitti; T Rago; F Mancusi; S Pallini; M Tonacchera; F Santini; L Chiovato; C Marcocci; A Pinchera Journal: Acta Endocrinol (Copenh) Date: 1992-02
Authors: A Loviselli; A Oppo; F Velluzzi; F Atzeni; G L Mastinu; P Farci; G Orgiana; A Balestrieri; P L Cocco; S Mariotti Journal: J Endocrinol Invest Date: 1999-10 Impact factor: 4.256
Authors: P Vitti; T Rago; S Mazzeo; S Brogioni; M Lampis; A De Liperi; C Bartolozzi; A Pinchera; E Martino Journal: J Endocrinol Invest Date: 1995-12 Impact factor: 4.256
Authors: S Mariotti; A Loviselli; S Murenu; F Sau; L Valentino; A Mandas; S Vacquer; E Martino; A Balestrieri; M E Lai Journal: J Endocrinol Invest Date: 1999-01 Impact factor: 4.256
Authors: F Aghini-Lombardi; L Antonangeli; E Martino; P Vitti; D Maccherini; F Leoli; T Rago; L Grasso; R Valeriano; A Balestrieri; A Pinchera Journal: J Clin Endocrinol Metab Date: 1999-02 Impact factor: 5.958
Authors: T Rago; W Bencivelli; M Scutari; C Di Cosmo; C Rizzo; P Berti; P Miccoli; A Pinchera; P Vitti Journal: J Endocrinol Invest Date: 2006-05 Impact factor: 4.256
Authors: Mijin Kim; Tae Yong Kim; Soo Han Kim; Yunkyoung Lee; Su-yeon Park; Hyung-Don Kim; Hyemi Kwon; Yun Mi Choi; Eun Kyung Jang; Min Ji Jeon; Won Gu Kim; Young Kee Shong; Won Bae Kim Journal: Korean J Intern Med Date: 2015-04-29 Impact factor: 2.884
Authors: T Rago; V Cantisani; F Ianni; L Chiovato; R Garberoglio; C Durante; A Frasoldati; S Spiezia; R Farina; G Vallone; A Pontecorvi; P Vitti Journal: J Endocrinol Invest Date: 2018-10-16 Impact factor: 4.256
Authors: I Muller; A Pinchera; E Fiore; V Belardi; V Rosellini; E Giustarini; C Giani Journal: J Endocrinol Invest Date: 2010-07-01 Impact factor: 4.256